期刊文献+

双硫仑抗肿瘤机制及治疗三阴性乳腺癌的研究进展 被引量:3

原文传递
导出
摘要 乳腺癌是目前全世界最常见的女性恶性肿瘤,也是全球女性癌症死亡的首要原因。美国癌症协会最新统计结果显示,2012年全球大约有170万例新发乳腺癌患者,占全球女性恶性肿瘤发病率的25%。全年约有52万女性死于乳腺癌,占全球女性恶性肿瘤死亡率的15%[1]。根据2015年的国家癌症中心最新报告,我国乳腺癌新发病例数约25万,居所有恶性肿瘤的第2位;在女性恶性肿瘤发病率中则居第1位[2]。2000年,
出处 《中国妇幼保健》 CAS 2016年第7期1553-1556,共4页 Maternal and Child Health Care of China
基金 吉林省科技厅课题(20150312033ZG)
  • 相关文献

参考文献44

  • 1Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA:a cancer journal for clinicians,2015,1:1-10.
  • 2陈万青,郑荣寿,曾红梅,邹小农,张思维,赫捷.2011年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2015,24(1):1-10. 被引量:865
  • 3Perou CM,Srlie T,Eisen MB,et al.Molecular portraits of human breast tumors[J].Nature,2000,406(6797):747-752.
  • 4Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clin Cancer Res,2007,13(15):4429-4434.
  • 5Bauer KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor(ER)-negative,progesterone receptor(PR)-negative,and HER2-negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California cancer Registry[J].Cancer,2007,109(9):1721-1728.
  • 6Liedtke C,Mazouni C,Hess KR,et al.Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer[J].J Clin Oncol,2008,26(8):1275-1281.
  • 7Silver DP,Richardson AL,Eklund AC,et al.Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer[J].J Clin Oncol,2010,28(7):1145-1153.
  • 8Byrski T,Gronwald J,Huzarski T,et al.Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy[J].J Clin Oncol,2010,28(3):375-379.
  • 9Vollebergh MA,Lips EH,Nederlof PM,et al.An a CGH classifier derived from BRCA1-mutated breast cancer and benefit of highdose platinum-based chemotherapy in HER2-negative breast cancer patients[J].Ann Oncol,2011,22(7):1561-1570.
  • 10Wang W,Mc Leod HL,Cassidy J.Disulfiram-mediated inhibition of NF-kappa B activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines[J].Int J Cancer,2003,104(4):504-511.

二级参考文献10

  • 1全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 2赫捷,赵平,陈万青.2012年中国肿瘤登记年报[M].北京:军事医学科学出版社,2012.56-59.
  • 3Curado MPEB,Shin HR,Storm H,et al. Cancer Inci- dence in Five Continents,Vol. IX [M] . Lyon: IARC Sci- entific Publication,2008. 1-837.
  • 4Felay L, Burkhard C,Whe|an S,et al. Cheek and Conver- sion Programs for Cancer Registries. IARC Technical Re- port No.42[M]. Lyon : IARC, 2005.
  • 5Bray F,Parkin DM. Evaluation of data quality in the can- cer registry:principles and methods. Part I :comparabili- ty, validity and timeliness [J]. Eur J Cancer, 2009,45 (5).. 747-755.
  • 6Parkin DM,Chen VW,Ferlay J,et al. Comparability and Quality Control in Cancer Registration. |ARC Technical Report No.19[M]. Lyon:|ARC, 1994-.
  • 7Felay J. The IARCcrgTools program[EB/OL], http://www.i- acr.com.fr/iarccrgtoo|s.htm.
  • 8Allemani C,Weir HK,Carrira H,et al. Global surveil- lance of cancer survival 1995-2009 :analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)[J]. Lancet,2014, Nov 26.[Epub ahead of print].
  • 9Zeng H,Zheng R,Guo Y,et al. Cancer survival in China, 2003-2005:a popuLation-based study [J]. lnt J Cancer, 2014,Sep20. [Epub ahead of print].
  • 10Chen W,Zheng R,Zhang S,et al. Report of cancer inci- dence and mortality in China,2010 [J]. Ann Transl Med, 2014,2(7):61.

共引文献864

同被引文献23

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部